CN1909885A - Skin whitening composition having synergic whitening effect - Google Patents
Skin whitening composition having synergic whitening effect Download PDFInfo
- Publication number
- CN1909885A CN1909885A CNA2005800023623A CN200580002362A CN1909885A CN 1909885 A CN1909885 A CN 1909885A CN A2005800023623 A CNA2005800023623 A CN A2005800023623A CN 200580002362 A CN200580002362 A CN 200580002362A CN 1909885 A CN1909885 A CN 1909885A
- Authority
- CN
- China
- Prior art keywords
- extract
- skin
- whitening
- papain
- ginseng rubra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 230000002087 whitening effect Effects 0.000 title claims abstract description 43
- 230000002195 synergetic effect Effects 0.000 title description 2
- 239000000284 extract Substances 0.000 claims abstract description 97
- 108090000526 Papain Proteins 0.000 claims abstract description 31
- 239000004365 Protease Substances 0.000 claims abstract description 31
- 235000019834 papain Nutrition 0.000 claims abstract description 31
- 229940055729 papain Drugs 0.000 claims abstract description 31
- 239000002537 cosmetic Substances 0.000 claims abstract description 9
- 241000208340 Araliaceae Species 0.000 claims description 32
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 32
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 32
- 235000008434 ginseng Nutrition 0.000 claims description 32
- 235000001553 Betula platyphylla Nutrition 0.000 claims description 29
- 241001313086 Betula platyphylla Species 0.000 claims description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 14
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 8
- 229960004705 kojic acid Drugs 0.000 claims description 8
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- 229960000271 arbutin Drugs 0.000 claims description 7
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 7
- 235000019155 vitamin A Nutrition 0.000 claims description 7
- 239000011719 vitamin A Substances 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- 238000005282 brightening Methods 0.000 claims description 4
- 239000013589 supplement Substances 0.000 claims 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 42
- 230000000694 effects Effects 0.000 abstract description 15
- 229940069445 licorice extract Drugs 0.000 abstract description 3
- 244000274847 Betula papyrifera Species 0.000 abstract description 2
- 235000009113 Betula papyrifera Nutrition 0.000 abstract description 2
- 235000009109 Betula pendula Nutrition 0.000 abstract description 2
- 235000010928 Betula populifolia Nutrition 0.000 abstract description 2
- 235000002992 Betula pubescens Nutrition 0.000 abstract description 2
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 52
- 238000002360 preparation method Methods 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 238000009472 formulation Methods 0.000 description 12
- 239000006101 laboratory sample Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 210000002615 epidermis Anatomy 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000001629 suppression Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000007758 minimum essential medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000228168 Penicillium sp. Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 description 1
- 229940093767 glabridin Drugs 0.000 description 1
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 description 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 108010001078 naringinase Proteins 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B35/00—Screw-bolts; Stay-bolts; Screw-threaded studs; Screws; Set screws
- F16B35/04—Screw-bolts; Stay-bolts; Screw-threaded studs; Screws; Set screws with specially-shaped head or shaft in order to fix the bolt on or in an object
- F16B35/06—Specially-shaped heads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B23/00—Specially shaped nuts or heads of bolts or screws for rotations by a tool
- F16B23/0007—Specially shaped nuts or heads of bolts or screws for rotations by a tool characterised by the shape of the recess or the protrusion engaging the tool
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B37/00—Nuts or like thread-engaging members
- F16B37/14—Cap nuts; Nut caps or bolt caps
Abstract
The present invention relates to a skin-whitening cosmetic composition, that prevents melanin hypersynthesis and promotes exhaustion of systhesized melanin from the skin. More particularily, the skin-whitening cosmetic composition of the prevent invention comprises licorice extract with red ginseng extract, white birch extract and papain, and thus has an excellent skin-whitening effect by improving that of the licorice extract, which is the whitening component.
Description
Technical field
The present invention relates to the skin-whitening cosmetic compositions, said composition can prevent melanin excessively synthetic (hypersynthesis), and promotes the melanin that is generated to be discharged by skin.More specifically, skin-whitening cosmetic compositions of the present invention contains Radix Glycyrrhizae extract (licorice extract) and Radix Ginseng Rubra extract (redginseng extract), Betula platyphylla Suk. extract (white birch extract) and papain (papain), so said composition has excellent skin whitening effect by improving as the effect of brightening the Radix Glycyrrhizae extract of component.
Background technology
When people's skin during by ultraviolet radiation, will produce and discharge the melanin of decider's skin color, thereby cause hyperpigmentation, as melasma, freckle and speckle, they all produce bad influence to beauty treatment.
Melanic building-up process is as follows: the tryrosinase in the cell forms DOPA quinone (dopaquinone) to the tyrosine effect, thereby produces melanin.Therefore, in order to prevent skin darkening, research worker is devoted to research and is suppressed melanic partial synthesis process, thereby reduces the synthetic of melanin self.This brightening agent example of exploitation is kojic acid (kojic acid), arbutin, Radix Glycyrrhizae extract, vitamin A and vitamin C.
In addition, except the decision skin color, melanin such as by forming around the medicated cap spline structure of nucleon and protecting group because of avoiding uv damage, and protect in the albumen in the cell by the elimination free radical and also to play an important role.As a result, the synthetic of melanin self may be excessively suppressed, thereby its minimum must acting in skin can not be finished.
Therefore, the best way is optionally rapidly to eliminate excessive synthetic melanin and the colour of skin is brightened.
Summary of the invention
For addressing these problems, the present inventor has carried out the research of three aspects, is intended to improve the skin whitening effect relevant with skin texture.
As a result, the present inventor finds, can promote the skin whitening effect by making skin renewal mechanism reach maximization, and this mechanism has adopted 1. papain, is intended to improve the separation of the outermost layer cell of keratin layer; 2. Radix Ginseng Rubra extract is intended to stimulating cellular growth; 3. the Betula platyphylla Suk. extract is intended to make rough skin soft and smooth, thereby has finished the present invention.
Therefore, the purpose of this invention is to provide a kind of method that makes the skin whitening maximum effect that brightens component.For realizing purpose of the present invention, provide the cosmetic composition that contains Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and papain.
Another object of the present invention provides the skin-whitening cosmetic compositions that contains as Radix Glycyrrhizae extract and Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and the papain of brightening agent.
The specific embodiment
The invention provides the skin-whitening cosmetic compositions that contains Radix Glycyrrhizae extract, Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and papain.
Compositions of the present invention can promote the skin whitening effect, and this is because to have suppressed melanin excessively synthetic and promoted to get rid of excessive synthetic melanin.And then by promoting that cell peels off, cell forms and skin is soft and smooth, compositions can be carried out the skin renewal cycle rapidly.
The present inventor finds, compares with the single component of independent employing, and when compositions comprised Radix Glycyrrhizae extract, Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and papain mixture, the skin whitening effect of compositions had unexpectedly improved.That is to say that when compositions contained by blended each component, it had maximized skin whitening effect.Below, the skin whitening composition that will contain Radix Glycyrrhizae extract, Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and papain is called " the energy complex of whitening (WhiteEnergy Complex) ".
Be used for described Radix Glycyrrhizae extract of the present invention for suppressing the key component that melanin forms.The content of Radix Glycyrrhizae extract is preferably the 0.001-2.0 weight % of composition total weight.If its content is lower than 0.001 weight %, then can not obtain the skin whitening effect, and, if surpass 2.0 weight %, may cause skin irritation.
The effect of papain mainly is to promote that Skin Cell peels off.The content of papain is preferably the 0.01-0.1 weight % of composition total weight.If its content is lower than 0.01 weight %, then can not obtain the skin whitening effect, and, if surpass 0.1 weight %, may cause skin irritation.
The effect of Radix Ginseng Rubra extract mainly is a stimulating cellular growth.Consider cost and effect, preferably adopt 6 years living Radix Ginseng Rubra extracts.The content of Radix Ginseng Rubra extract is preferably 0.01-5.0 weight %.If its content is lower than 0.01 weight %, then can not obtain the skin whitening effect, and if surpass 5.0 weight %, the cost of product can increase.
The Betula platyphylla Suk. extract then helps skin soft and smooth.The content of Betula platyphylla Suk. extract is preferably the 0.01-5.0 weight % of composition total weight.If its content is lower than 0.01 weight %, then can not obtain the skin whitening effect, and, if surpass 5.0 weight %, may cause skin irritation.
By described each component is mixed, will demonstrate synergy, and aforesaid effect.
In addition, the present invention can adopt kojic acid, arbutin, vitamin A or vitamin C to replace Radix Glycyrrhizae extract as the active key component of skin whitening.
The present invention is below described in more detail.
The skin whitener of having developed up till now can be suppressed in the melanin generation and play the activity of the tryrosinase of most important effect, thereby reduces melanic amount.But the problem of this skin whitener is that they can cause skin irritant side effect, so consumption is limited.Therefore, compositions of the present invention promotes the active system of skin renewal to promote the skin whitening effect of the skin whitener of exploitation at present owing to having adopted, thereby excellent skin whitening effect is provided.
Skin is made up of epidermis and corium, and epidermis is shallow top layer, and corium is subepidermal more deep layer.Be different connective tissue layers (subcutaneous tissue (hypodermic tissue)) below corium, be referred to as " subcutaneous tissue (subcutaneous tissue) ".The skin of the skin that epidermis is made up of epithelial tissue, and constitute by five layers.Specifically, from the inboard, epidermis is by basic unit, spinous layer (spinous layer), granular layer (granular layer), clear layer (clear layer) and horny layer (homy layer); Epidermis forms new cell in the bottom, then, new cell stretches out continuously, separates with cornified dead cell gradually.Aforesaid circulation is called as " upgrade (turnover) ", and wherein, synthetic new cell upwards is pushed into old cell the skin of health in the bottom, with in this separation.By promoting renewal, compositions of the present invention is expelled to the melanin that forms in the epidermis external rapidly.
By following embodiment, comparative example and experimental example the present invention is described in more detail.But those skilled in the art know that clearly these examples only are used for explanation, are not considered as limiting the scope of the invention.
<embodiment 1 and 2〉preparation skin whitening composition (the energy complex 1 and 2 of whitening)
Buy " polyhydric alcohol solubility Radix Glycyrrhizae extract P-T (40) " as described Radix Glycyrrhizae extract, it comprises and surpasses 35% glabridin, is produced by Maruzen Pharmaceuticals Co.Ltd (Japan).
Radix Ginseng Rubra extract prepares according to following process, and 6 years living Radix Ginseng Rubra extracts being produced by Bioland (Korea S) are carried out enzymolysis.
" enzymolysis process "
10 gram Radix Ginseng Rubra extracts are dissolved in 100 milliliters of citrate buffers (pH 5.5), add the naringinase of 1 gram from penicillium (Penicillium sp.), then, with mixture 40 ℃ stirred in water bath 48 hours.When regularly determining, mixture is carried out 10 minutes hot water heat (hydrothermally heated), then, carry out three extractions and concentrated with identical ether with cessation reaction when the material disappearance and by thin layer chromatography.(chloroform: assay products methanol=9: 1) obtains Radix Ginseng Rubra extract (10.5% yield) with silica gel column chromatography.
The Betula platyphylla Suk. extract is available from " the Betula platyphylla Suk. extract " produced by Arch Personal Care Products (U.S.).
Papain is available from " the refining papain powder (Refined papain powder) " produced by CPC Wolfgang Muhlbauer GmbH (Germany).
With Radix Glycyrrhizae extract, Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and papain with 5: 5: 10: 0.3 mixed, make 203 the gram skin whitening compositions 1 (energy complex 1: embodiment 1 whitens).
In addition, with Radix Glycyrrhizae extract, Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and papain with 5: 10: 20: 0.6 mixed, the preparation 356 the gram skin whitening compositions 2 (energy complex 2: embodiment 2 whitens).
<experimental example 1〉measure and suppress the effect that melanin forms
Will be as the HM3KO cell (Y.Funasaka of people's melanoma cell, Department ofDermatology, Kobe University School of Medicine, 5-1 Kusunoki-cho7-chrome, Chuo-ku, Kobe 650, Japan) place contain 10% N of embryo's serum minimum essential medium (Minimum Essential Medium) (MEM), and at 37 ℃ and 5% CO
2Condition under cultivate.Cultured cells is applied in the bottom of 75 hole flasks, and cell number is 3 * 10
5/ hole, placement is spent the night, thereby makes cell adhesion on wall.After the affirmation, each culture medium is become the new culture medium that contains the 10ppm laboratory sample.
The laboratory sample that adopts is as shown in table 1 below.
Matched group adopts the culture medium that contains DMSO (dimethyl sulfoxide).
For comparing the effect of each component, adopting each component separately is that Radix Glycyrrhizae extract, kojic acid, arbutin, vitamin A, vitamin C, Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and papain experimentize, and, adopt the mixture that some components in these components is mixed with the form of combination and form to experimentize.
In the above described manner, once every kind of culture medium was become the new culture medium that contains laboratory sample, and be enough to be full of flask in per 2 days until cultured cells.Then, take out culture fluid, with PBS (phosphate buffer) washing, be dissolved among the NaOH of 1N again, (opticaldensity OD), calculates the suppression ratio that melanin forms with following formula 1 to the optical density of measurement under 500 nanometers.The result is as shown in table 1.
General formula 1
Melanin forms suppression ratio (%)={ 1-(OD of the OD/ matched group of each laboratory sample) } * 100
Table 1
Laboratory sample (concentration) | Melanin forms suppression ratio (%) |
Radix Glycyrrhizae extract (1ppm) | 23.1 |
Kojic acid (1ppm) | 20.2 |
Arbutin (1ppm) | 20.5 |
Vitamin A (1ppm) | 19.7 |
Vitamin C (1ppm) | 20.3 |
Papain (3ppm) | 0.5 |
Radix Ginseng Rubra extract (5ppm) | 1.1 |
Betula platyphylla Suk. extract (10ppm) | 1.6 |
Radix Glycyrrhizae extract (1ppm)+papain (3ppm) | 24.2 |
Radix Glycyrrhizae extract (1ppm)+Radix Ginseng Rubra extract (5ppm) | 24.8 |
Radix Glycyrrhizae extract (1ppm)+Betula platyphylla Suk. extract (10ppm) | 24.5 |
Radix Glycyrrhizae extract (1ppm)+papain (3ppm)+Radix Ginseng Rubra extract (5ppm) | 25.2 |
Radix Glycyrrhizae extract (1ppm)+Radix Ginseng Rubra extract (5ppm)+Betula platyphylla Suk. extract (10ppm) | 26.3 |
Radix Glycyrrhizae extract (1ppm)+papain (3ppm)+Betula platyphylla Suk. extract (10ppm) | 26.9 |
Kojic acid (1ppm)+papain (3ppm)+Radix Ginseng Rubra extract (5ppm) | 25.4 |
Arbutin (1ppm)+Radix Ginseng Rubra extract (5ppm)+Betula platyphylla Suk. extract (10ppm) | 24.9 |
Vitamin A (1ppm)+Radix Ginseng Rubra extract (5ppm)+Betula platyphylla Suk. extract (10ppm) | 22.4 |
Vitamin C (1ppm)+papain (3ppm)+Betula platyphylla Suk. extract (10ppm) | 25.8 |
Embodiment 1 (the energy complex 1 of whitening) | 35.6 |
Embodiment 2 (the energy complex 2 of whitening) | 37.2 |
Shown in table 1 result, can confirm, the described papain, Radix Ginseng Rubra extract and the Betula platyphylla Suk. extract that constitute the energy complex of whitening only have lower melanin and form suppression ratio when using separately, and when one or both of described component are used in combination with Radix Glycyrrhizae extract, has higher skin whitening effect, and, when three kinds of described components are mixed use, demonstrate the highest skin whitening effect.
In addition, when known skin whitener kojic acid, arbutin, vitamin A and vitamin C and papain, Radix Ginseng Rubra extract and Betula platyphylla Suk. extract combination are used, confirm that the skin whitening effect of compositions is enhanced.
<experimental example 2〉to the skin whitening effect of human body skin
The opaque adhesive tape that will have 6 diameters and be a hole of 1.5 centimetres adheres on 10 healthy men's everyone upper arm, with intensity is 1.5-2 ultraviolet light beam (the UV beam doubly of the minimum Erythema Dose of each subject (Minimal Erythema Dose), UVB) shine, to induce the dermal melanin deposition.Smear laboratory sample then, after 2 months, use the chromatmetry instrument to measure the degree of depth (darkness) of skin.
According to the composition preparation experiment sample in the table 2, smeared the preparation of embodiment in twice table 2 and comparative formulations (sooner or later each once) in one day.
<preparation 1-5 and comparative formulations 1-4 〉
Preparation is O/W (oil-in-water) lotion, and unit is weight %.The viscosity of the preparation of preparation is the 7000-11000 centipoise, the 2nd day measurement of described viscosity after each preparation places 30 ℃ of constant temperature baths, and pH (10% solution is the basis) is 6.5-7.5.
" preparation method "
(1) makes oil-soluble (oily) composition 1 uniform mixing by heating down at 70-75 ℃.
(2) make water solublity (aqueous) composition 1 dissolving and uniform mixing by heating down at 70-75 ℃.
(3) stir water soluble mixt (2) down at 70-75 ℃, add described oil-soluble mixture (1), make emulsion, add oil-soluble composition 2 and water soluble ingredient 2 then continuously, the mixture that forms is cooled to 28-30 ℃.
Table 2
Composition | Component (weight %) | Preparation 1 | Preparation 2 | Preparation 3 | Preparation 4 | Preparation 5 | Comparative formulations 1 | Comparative formulations 2 | Comparative formulations 3 | Comparative formulations 4 |
Oil-soluble composition 1 | Stearic acid | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
Spermol | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
Hydrogenated oil and fat | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
The lipotropy tristerin | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
Polyglyceryl-3 methyl glucoside distearate | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |
Antiseptic | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
Hydrogenated polydecene | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | |
Bai Manghua seed oil | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | |
Oleum Helianthi | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |
Dimethicone | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
Octanoic acid, hexadecyl ester | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | |
Cupu oil ester in the last of the ten Heavenly stems (Decylcocoate) | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |
Ring first silicon fat (Cyclomethicone) | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | |
Tocopherol acetas | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
Water soluble ingredient 1 | Purified Water | To 100 | To 100 | To 100 | To 100 | To 100 | To 100 | To 100 | To 100 | To 100 |
Glycerol | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | |
Butanediol | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | |
Disodiumedetate | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Triethanolamine (TEA) | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | |
Antiseptic | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
Trehalose | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |
Hyaluronic acid | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | |
Radix Glycyrrhizae extract | - | - | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
The Betula platyphylla Suk. extract | - | - | 0.1 | 0.1 | - | - | 0.1 | - | - | |
Papain | - | - | 0.003 | - | 0.003 | - | - | 0.003 | - | |
Radix Ginseng Rubra extract | - | - | - | 0.05 | 0.05 | - | - | - | 0.05 | |
Embodiment 1 (the energy complex 1 of whitening) | 0.153 | - | - | - | - | - | - | - | - | |
Embodiment 2 (the energy complex 2 of whitening) | - | 0.306 | - | - | - | - | - | - | - | |
Water soluble ingredient 2 | 1% carbomer (carbomer) solution | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 |
Oil-soluble composition 2 | Spice | Quantity of stimulus (q.s.) | Quantity of stimulus | Quantity of stimulus | Quantity of stimulus | Quantity of stimulus | Quantity of stimulus | Quantity of stimulus | Quantity of stimulus | Quantity of stimulus |
" L " value that adopt to show the skin Lightening degree is come determine effect (" L " value of the Korean who is burnt by the sun is not generally 50-70).If produced effect by smearing laboratory sample, then L-value can increase.Come the comparative experiments sample by value Δ L (L-value before last L-value-the smear laboratory sample).The Δ L-value is big more, and then the skin whitening effect is big more.Δ L is as shown in table 3 below.
Table 3
Laboratory sample | Skin whitening effect (Δ L) |
Preparation 1 | 3.36 |
Preparation 2 | 3.72 |
Preparation 3 | 3.10 |
Preparation 4 | 3.11 |
Preparation 5 | 3.07 |
Comparative formulations 1 | 2.02 |
Comparative formulations 2 | 2.21 |
Comparative formulations 3 | 2.32 |
Comparative formulations 4 | 2.45 |
Result shown in the table 3 confirms, the Δ L-value that contains Radix Glycyrrhizae extract and be selected from the group of being made up of papain, Betula platyphylla Suk. extract and Radix Ginseng Rubra extract at least two kinds preparation 1-5 will be higher than the Δ L-value of the comparative formulations 1 that only contains Radix Glycyrrhizae extract, also be higher than and contain Radix Glycyrrhizae extract and Betula platyphylla Suk. extract respectively, Radix Glycyrrhizae extract and papain, the comparative formulations 2-4 of Radix Glycyrrhizae extract and Radix Ginseng Rubra extract.Particularly, it is the highest containing the preparation 1 of the energy complex of whitening of three kinds of components and 2 Δ L-value, thereby preparation 1 demonstrates relative higher skin whitening effect with 2 than other preparation.
In addition, confirm also that if the amount of the energy complex of whitening increases, then preparation can increase the skin whitening effect relatively.
As mentioned above, verified, the cosmetic composition of adopting the O/w emulsion of the energy complex preparation of whitening of the present invention has improved the skin whitening effect.
Claims (4)
1, a kind of active skin whitening supplement composition of skin whitener that improves, said composition contains at least two kinds of components that are selected from the group of being made up of Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and papain.
2, compositions according to claim 1, wherein, described skin whitener be selected from the group of forming by kojic acid, arbutin, Radix Glycyrrhizae extract, vitamin A and vitamin C at least a.
3, a kind of skin-whitening cosmetic compositions, said composition contain Radix Glycyrrhizae extract as brightening component, it is characterized in that said composition also contains at least two kinds of components that are selected from the group of being made up of Radix Ginseng Rubra extract, Betula platyphylla Suk. extract and papain.
4, compositions according to claim 3, wherein, in the gross weight of compositions, described components contents is: Radix Glycyrrhizae extract 0.001-2.0 weight %, papain 0.01-0.1 weight %, Radix Ginseng Rubra extract 0.01-5.0 weight % and Betula platyphylla Suk. extract 0.01-5.0 weight %.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040002910A KR101072133B1 (en) | 2004-01-15 | 2004-01-15 | Skin whitening composition having synergic whitening effect |
KR1020040002910 | 2004-01-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1909885A true CN1909885A (en) | 2007-02-07 |
CN100459970C CN100459970C (en) | 2009-02-11 |
Family
ID=34793252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005800023623A Expired - Fee Related CN100459970C (en) | 2004-01-15 | 2005-01-14 | Skin whitening composition having synergic whitening effect |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP4660487B2 (en) |
KR (1) | KR101072133B1 (en) |
CN (1) | CN100459970C (en) |
WO (1) | WO2005067885A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102665667A (en) * | 2009-11-30 | 2012-09-12 | 株式会社爱茉莉太平洋 | Topical composition for skin containing polysaccharide extract of red ginseng |
CN104056036A (en) * | 2013-03-21 | 2014-09-24 | 刘宝英 | Health care composition capable of whitening and removing freckle |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100841276B1 (en) * | 2006-12-18 | 2008-06-25 | 한국식품연구원 | Skin Whitening Composition Containing Ethyl Acetate Fraction of White Ginseng with High Whitening Activity |
WO2009067095A1 (en) * | 2007-11-19 | 2009-05-28 | Stiefel Laboratories, Inc. | Topical cosmetic skin lightening compositions and methods of use thereof |
US9364424B2 (en) | 2007-11-19 | 2016-06-14 | Stiefel Laboratories, Inc. | Topical cosmetic skin lightening compositions and methods of use thereof |
US9241893B2 (en) | 2007-11-19 | 2016-01-26 | Stiefel Laboratories, Inc. | Topical cosmetic skin lightening compositions and methods of use thereof |
JP5414236B2 (en) * | 2008-10-10 | 2014-02-12 | 丸善製薬株式会社 | Anti-inflammatory agent |
US8440237B2 (en) | 2009-04-27 | 2013-05-14 | Mary Kay Inc. | Botanical anti-acne formulations |
WO2013096485A1 (en) | 2011-12-19 | 2013-06-27 | Mary Kay Inc. | Combination of plant extracts to improve skin tone |
EP3116469B1 (en) * | 2014-03-10 | 2018-10-03 | Mary Kay, Inc. | Skin lightening compositions |
JP6583704B2 (en) * | 2014-09-25 | 2019-10-02 | ポーラ化成工業株式会社 | Screening method for pigmentation improvers |
KR101707107B1 (en) | 2015-05-20 | 2017-02-16 | 주식회사 콧데 | Composition for multi-functional activation comprising Liquiritigenin |
WO2017052242A1 (en) * | 2015-09-23 | 2017-03-30 | (주)아모레퍼시픽 | Lightening composition comprising ginseng-derived exosome-like vesicles |
KR102598793B1 (en) * | 2015-09-23 | 2023-11-07 | (주)아모레퍼시픽 | Composition comprising ginseng derived exosome like vesicles for skin whitening |
KR101682123B1 (en) | 2015-10-12 | 2016-12-02 | (주)솔티패밀리그룹 | Cosmetic composition comprising birch sap and herbal extracts for skin whitening and improvement of skin barrier function, and cosmetic comprising the same |
KR101866742B1 (en) | 2015-11-19 | 2018-06-12 | 대봉엘에스 주식회사 | METHOD FOR PREPARING AN LICORICE EXTRACT OF Nrf-2 ACTIVATOR, AND COSMETIC COMPOSITION COMPRISING THE SAME |
KR102207684B1 (en) | 2019-06-07 | 2021-01-26 | 안준민 | Cosmetic composition for skin whitening comprising black-ginseng fermentation extract |
CN112386548A (en) * | 2020-11-13 | 2021-02-23 | 深圳市薇美经典科技发展有限公司 | Freckle-removing skin-brightening preparation and preparation method thereof |
KR102422661B1 (en) | 2020-12-24 | 2022-07-19 | 제너럴바이오(주) | Composition comprising fermented Glycyrrhiza uralensis extract for inhibitory effects on melanogenesis of B16F10 cells |
KR102566401B1 (en) | 2020-12-30 | 2023-08-14 | 제너럴바이오(주) | a composition comprising Fomitella fraxinea mycelium, Ganoderma applanatum mycelium and Glycyrrhizae uralensis extract for inhibitory effects on melanogenesis of B16F10 cells |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020063877A (en) * | 1999-10-14 | 2002-08-05 | 니신 오일 밀스 가부시키가이샤 | Skin-care agents, skin antiaging agents, whitening agents and external skin preparations |
JP3958968B2 (en) * | 2000-03-31 | 2007-08-15 | 日清オイリオグループ株式会社 | External preparation for skin and whitening agent |
JP2001335498A (en) * | 2000-05-26 | 2001-12-04 | Nippon Flour Mills Co Ltd | Bleaching composition and food and cosmetic comprising the same |
KR100357416B1 (en) * | 2000-08-22 | 2002-10-19 | 오세군 | Compositions of whitening cosmetics containing special herbal extracts |
KR100493845B1 (en) * | 2001-07-04 | 2005-06-08 | 한국화장품주식회사 | Whitening cosmetic composition containing the extract of mountain ginseng adventitious roots |
JP2003081751A (en) * | 2001-09-07 | 2003-03-19 | Sanburen:Kk | Papaya powder-formulated water-containing cosmetic |
JP3784730B2 (en) | 2002-02-25 | 2006-06-14 | 株式会社カネボウ化粧品 | Whitening cosmetics |
-
2004
- 2004-01-15 KR KR1020040002910A patent/KR101072133B1/en active IP Right Grant
-
2005
- 2005-01-14 CN CNB2005800023623A patent/CN100459970C/en not_active Expired - Fee Related
- 2005-01-14 JP JP2006549140A patent/JP4660487B2/en active Active
- 2005-01-14 WO PCT/KR2005/000146 patent/WO2005067885A1/en active Application Filing
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102665667A (en) * | 2009-11-30 | 2012-09-12 | 株式会社爱茉莉太平洋 | Topical composition for skin containing polysaccharide extract of red ginseng |
US8691794B2 (en) | 2009-11-30 | 2014-04-08 | Amorepacific Corporation | Topical composition for skin containing polysaccharide extract of red ginseng |
CN102665667B (en) * | 2009-11-30 | 2014-10-29 | 株式会社爱茉莉太平洋 | Topical composition for skin containing polysaccharide extract of red ginseng |
CN104056036A (en) * | 2013-03-21 | 2014-09-24 | 刘宝英 | Health care composition capable of whitening and removing freckle |
Also Published As
Publication number | Publication date |
---|---|
CN100459970C (en) | 2009-02-11 |
WO2005067885A1 (en) | 2005-07-28 |
KR101072133B1 (en) | 2011-10-10 |
JP2007517866A (en) | 2007-07-05 |
JP4660487B2 (en) | 2011-03-30 |
KR20050075115A (en) | 2005-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1909885A (en) | Skin whitening composition having synergic whitening effect | |
CN101102746B (en) | Skin-condition improving composition comprising vaccinium uliginosum extract and method for preparation thereof | |
EP2689784B1 (en) | A ginseng berry extract for use in the treatment of vascular inflammation | |
US9801809B2 (en) | Compositions including a botanical extract and methods of using the same in skin whitening and skin lightening applications | |
CN1256914A (en) | Skin brightening composition containing Arctostaphylos ura-ursi extract and reductant | |
CN101626773B (en) | Agent for promoting healing of living body | |
JP2009286746A (en) | External preparation containing cordyceps sinensis or cordyceps sobolifera | |
JP6850262B2 (en) | Skin anti-aging agents and anti-aging compositions | |
CN1607932A (en) | Methods for improving the aesthetic appearance of skin | |
CN100335062C (en) | Use of Ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition contg. same | |
EP2596787A1 (en) | New use of hesperetin | |
JP2019112354A (en) | Antiinflammatory agent and antiinflammatory composition | |
CN104254328B (en) | CGRP responsiveness accelerator | |
KR20150063485A (en) | Vegfc production promoter | |
KR20030062562A (en) | The culture medium for Kombucha fermentation, that has functions of skin regeneration and anti-aging, and composition containing thereof | |
KR101452061B1 (en) | Agents for skin whitening containing artemisinic acid, its derivatives and pharmaceutically acceptable salts thereof | |
JP4809162B2 (en) | Topical skin preparation | |
CN1171628C (en) | Ointment for eliminating macula and its preparation method | |
CN1319554C (en) | Medicine composition with spot dispelling function and preparation thereof | |
KR102569532B1 (en) | Cosmetic composition comprising strains of Staphylococcus genus, Streptococcus genus, Cutibacterium genus, Enhydrobacter and fragmented DNA mixture | |
CN108030762A (en) | Anti-oxidant rosemary stem cell extractive composition and the skin care item containing said composition | |
EP2783690B1 (en) | New use of neohesperidin | |
CN1148223C (en) | Enopeptin containing compound preparation and its medical use for controlling sutaneous pigmentation | |
KR100843168B1 (en) | Whitenning agent containing oligonucleotide | |
KR20160082113A (en) | Skin external composition for anti-anging comprising compound K and panaxydol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090211 Termination date: 20120114 |